enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

3. Category:Antiparkinsonian agents - Wikipedia

   en.wikipedia.org/wiki/Category:Antiparkinsonian...

   Generally, drugs outlined within the ATC code N04 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Antiparkinsonian agents .

4. Catechol-O-methyltransferase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Catechol-O-methyltransfer...

   COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino acid decarboxylase inhibitor (e.g. carbidopa or benserazide). The therapeutic benefit of using a COMT inhibitor is based on its ability to prevent the methylation of levodopa to 3- O -methyldopa , thus increasing the ...

5. Norepinephrine–dopamine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Norepinephrine–dopamine...

   A norepinephrine–dopamine reuptake inhibitor (NDRI) is a drug used for the treatment of clinical depression, attention deficit hyperactivity disorder (ADHD), narcolepsy, and the management of Parkinson's disease. The drug acts as a reuptake inhibitor for the neurotransmitters norepinephrine and dopamine by blocking the action of the ...

6. Trihexyphenidyl - Wikipedia

   en.wikipedia.org/wiki/Trihexyphenidyl

   Trihexyphenidyl (THP, benzhexol, trihex, marketed as Artane and others) is an antispasmodic drug used to treat stiffness, tremors, spasms, and poor muscle control. It is an agent of the antimuscarinic class and is often used in management of Parkinson's disease. It was approved by the FDA for the treatment of Parkinson's in the US in 2003. [2] [3]

7. Novel method may erase 'bad memory' response to long-term ...

   www.aol.com/novel-method-may-erase-bad-151501517...

   L-DOPA, a treatment for Parkinson’s disease, may induce dyskinesia Parkinson’s disease is a neurodegenerative disorder caused by the death of dopamine-producing neurons.